Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Accured Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Change in Accured Expenses for 16 consecutive years, with $958000.0 as the latest value for Q3 2025.

  • Quarterly Change in Accured Expenses rose 333.48% to $958000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Sep 2025, up 724.76% year-over-year, with the annual reading at -$2.9 million for FY2024, 176.95% down from the prior year.
  • Change in Accured Expenses for Q3 2025 was $958000.0 at Xtant Medical Holdings, up from $23000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.7 million in Q1 2025, with the low at -$1.6 million in Q3 2021.
  • Average Change in Accured Expenses over 5 years is $243526.3, with a median of $221000.0 recorded in 2024.
  • The sharpest move saw Change in Accured Expenses soared 10636.36% in 2021, then plummeted 788.78% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $270000.0 in 2021, then soared by 75.93% to $475000.0 in 2022, then skyrocketed by 198.74% to $1.4 million in 2023, then crashed by 175.55% to -$1.1 million in 2024, then soared by 189.37% to $958000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $958000.0, $23000.0, and $2.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.